ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025
Regio- and Stereocontrolled-Synthesis of a Heterocycle Fragment Collection Using Palladium Catalyzed C-H Arylation.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Saturated heterocycles are valuable fragments in drug discovery due to their polarity, 3D structure, and potential for versatile binding modes, yet their controlled functionalization remains challenging. Existing methods often require pre-functionalized substrates and provide limited control over substitution patterns, restricting access to diverse exit vectors. Here, we report a campaign achieving systematic control over the position and orientation of exit vectors in heterocycles through the synthesis of a structurally diverse fragment collection using aminoquinoline-directed C-H functionalization. The study prioritizes five- and six-membered N-heterocycles, as well as rings with sulfonyl and difluoromethylene units. Aminoquinoline directing groups installed at C(2), C(3), or C(4) enable β-arylation, and are subsequently removed to reveal carboxylic acids, primary amides, primary alcohols, or nitriles. The resulting 44 fragments, now part of AbbVie's compound collection, combine structural novelty with favorable physicochemical properties. Finally, a simple script is provided for rapid analysis of fragment properties.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.